📰 Time Dynamix News
Page 2 - Time Dynamix News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Time Dynamix. Real-time updates on events, politics, business and more.
February 17, 2023
/PRNewswire/ -- According to Biogens earnings call on Wednesday, February 15, 2023, sales for its multiple sclerosis (MS) franchise are down for the third...
February 9, 2023
/PRNewswire/ -- Since 2017, Spherix Global Insights has been monitoring the U.S. renal anemia market landscape, capturing nephrologists perceptions and...
January 20, 2023
/PRNewswire/ -- With SGLT2 inhibitors increasingly becoming the standard of care for diabetic and non-diabetic CKD patients, the broader CKD treatment has...
December 21, 2022
/PRNewswire/ -- Spherix Global Insights, a leading provider of market research, business intelligence, and advisory services to the global life sciences...
December 7, 2022
/PRNewswire/ -- On October 28, 2022, the European Medicines Agencys (EMA) safety committee (PRAC) announced recommendations to minimize the risk of serious...
December 6, 2022
/PRNewswire/ -- After a regulatory debacle in the United States which ended with FibroGen and AstraZeneca receiving a Complete Response Letter in August 2021...
December 6, 2022
/PRNewswire/ -- After a regulatory debacle in the United States which ended with FibroGen and AstraZeneca receiving a Complete Response Letter in August 2021...
November 10, 2022
/PRNewswire/ -- Rheumatologists in the EU5 (France, Germany, Italy, Spain, and the United Kingdom) recognize a disconnect in the diagnosis and referral process...
October 13, 2022
/PRNewswire/ -- TNF inhibitors continue to be the mainstay for treating psoriatic arthritis (PsA), largely driven by the gold standards, etanercept and...
October 13, 2022
/PRNewswire/ -- TNF inhibitors continue to be the mainstay for treating psoriatic arthritis (PsA), largely driven by the gold standards, etanercept and...